Harvard Bioscience (HBIO) announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. DeNelsky will also serve on the Board’s Nominating and Governance Committee.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HBIO:
- Harvard Bioscience Offers CFO $100K Retention Bonus
- Harvard Bioscience at Risk of Nasdaq Delisting: Implications for Investors and Business Stability
- Harvard Bioscience Reports Q2 2025 Financial Results
- Harvard Bioscience Surpasses Revenue Guidance Amid Challenges
- Harvard Bioscience Amends Credit Agreement with Lenders